SEC CIK 1282677
ABRAMS ROBIN ANN
Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| LSCCview stock → | 98,398 | 2026-02-13 |
| FDSview stock → | 15,115 | 2026-10-15 |
Position History — FDS
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — FDS
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-10-15 | Gift | 125 | $0.00 | 15,115 |
| 2026-10-15 | Gift | 125 | $0.00 | 15,240 |
| 2026-10-15 | Gift | 125 | $0.00 | 15,365 |
| 2026-01-15 | Grant / award (derivative) | 1,477 | $0.00 | 1,477 |
| 2026-01-15 | Grant / award | 604 | $0.00 | 15,490 |
| 2026-01-07 | Option exercise (derivative) | 2,572 | $0.00 | 0 |
| 2026-01-07 | Option exercise | 2,572 | $207.88 | 14,886 |
| 2025-01-15 | Grant / award (derivative) | 803 | $0.00 | 803 |
| 2025-01-15 | Grant / award | 431 | $0.00 | 12,314 |
| 2025-01-02 | Option exercise (derivative) | 2,838 | $0.00 | 0 |
| 2025-01-02 | Option exercise | 2,838 | $197.75 | 11,883 |
| 2024-12-20 | Gift | 74 | $0.00 | 9,119 |
| 2024-12-20 | Gift | 74 | $0.00 | 9,045 |
| 2024-06-25 | Open-market sale | 2,375 | $420.71 | 9,193 |
| 2024-01-16 | Grant / award (derivative) | 791 | $0.00 | 791 |
| 2024-01-16 | Grant / award | 230 | $0.00 | 11,568 |
| 2024-01-02 | Option exercise (derivative) | 3,086 | $0.00 | 0 |
| 2024-01-02 | Option exercise | 3,086 | $170.24 | 11,338 |
| 2023-01-17 | Grant / award (derivative) | 583 | $0.00 | 583 |
| 2023-01-17 | Grant / award | 176 | $0.00 | 8,252 |
| 2023-01-10 | Option exercise (derivative) | 3,545 | $0.00 | 0 |
| 2023-01-10 | Option exercise | 3,545 | $146.82 | 8,076 |
| 2022-04-26 | Open-market sale | 1,767 | $418.98 | 4,531 |
| 2022-01-18 | Grant / award (derivative) | 963 | $0.00 | 963 |
| 2022-01-18 | Grant / award | 248 | $0.00 | 6,298 |
| 2022-01-07 | Option exercise (derivative) | 2,307 | $0.00 | 0 |
| 2022-01-07 | Option exercise | 2,307 | $138.48 | 6,050 |
| 2021-01-15 | Grant / award (derivative) | 1,342 | $0.00 | 1,342 |
| 2021-01-05 | Option exercise (derivative) | 2,404 | $0.00 | 0 |
| 2021-01-05 | Open-market sale | 783 | $330.72 | 3,743 |
| 2021-01-05 | Option exercise | 2,404 | $107.65 | 4,526 |
| 2020-10-06 | Open-market sale | 100 | $326.44 | 2,122 |
| 2020-10-06 | Open-market sale | 1,100 | $325.27 | 2,222 |
| 2020-10-06 | Open-market sale | 200 | $323.78 | 3,322 |
| 2020-01-15 | Grant / award (derivative) | 2,010 | $0.00 | 2,010 |
| 2020-01-06 | Option exercise (derivative) | 2,683 | $0.00 | 0 |
| 2020-01-06 | Option exercise | 2,683 | $91.06 | 4,438 |
| 2020-01-06 | Open-market sale | 916 | $266.86 | 3,522 |
| 2019-06-26 | Open-market sale | 1,250 | $289.62 | 1,755 |
| 2019-01-15 | Grant / award (derivative) | 2,572 | $0.00 | 2,572 |
| 2019-01-10 | Option exercise (derivative) | 5,244 | $0.00 | 0 |
| 2019-01-10 | Option exercise | 5,244 | $87.26 | 5,244 |
| 2019-01-10 | Open-market sale | 200 | $205.10 | 3,005 |
| 2019-01-10 | Open-market sale | 2,039 | $204.39 | 3,205 |
| 2018-01-12 | Grant / award (derivative) | 2,838 | — | 22,107 |
| 2017-01-13 | Grant / award (derivative) | 3,086 | — | 19,269 |
| 2016-01-15 | Grant / award (derivative) | 3,545 | — | 16,183 |
| 2015-01-15 | Grant / award (derivative) | 2,307 | — | 12,638 |
| 2014-01-15 | Grant / award (derivative) | 2,404 | — | 10,331 |
| 2013-01-15 | Grant / award (derivative) | 2,683 | — | 7,927 |
| 2012-01-13 | Grant / award (derivative) | 5,244 | — | 5,244 |
| 2011-10-24 | — | — | — | 0 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.